[시장보고서]경비 약물전달 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 약물 유형별, 제형별, 치료 용도별, 최종사용자별, 지역별, 경쟁별(2020-2030년)

경비 약물전달 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 약물 유형별, 제형별, 치료 용도별, 최종사용자별, 지역별, 경쟁별(2020-2030년)

Nasal Drug Delivery Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type, By Dosage Form, By Therapeutic Application, By End User, By Region and Competition, 2020-2030F

상품코드 : 1878861

리서치사 : TechSci Research

발행일 : 2025년 11월

페이지 정보 : 영문 180 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,500

￦ 6,681,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500

￦ 8,165,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000

￦ 11,877,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

세계의 경비 약물전달 시장은 2024년에 596억 7,000만 달러로 평가되었으며, 2030년까지 CAGR 7.66%로 성장하여 929억 1,000만 달러에 달할 것으로 예측됩니다.

경비 약물전달은 풍부한 혈관 분포와 뇌로의 직접 접근 가능성을 활용하여 치료제를 비강 내로 직접 투여하여 국소적 또는 전신적 흡수를 촉진하는 방법입니다. 이 시장의 성장을 뒷받침하는 주요 요인으로는 비침습적 약물 투여에 대한 환자 선호도 증가, 빠른 약효 발현, 간에서의 첫 번째 통과 효과를 피할 수 있어 약물의 생체 이용률과 치료 효과를 종합적으로 향상시킬 수 있다는 점을 꼽을 수 있습니다. 또한, 만성 호흡기질환의 유병률 증가와 편의성이 높은 자가투여 방식에 대한 수요도 시장 확대에 크게 기여하고 있습니다.

시장 개요
예측 기간	2026-2030년
시장 규모 : 2024년	596억 7,000만 달러
시장 규모 : 2030년	929억 1,000만 달러
CAGR : 2025-2030년	7.66%
가장 빠르게 성장하는 부문	코르티코스테로이드
최대 시장	북미

주요 시장 촉진요인

주요 시장 과제

주요 시장 동향

시장 규모 및 예측
- 금액별
시장 점유율과 예측
- 약물 유형별(항히스타민제, 코르티코스테로이드, 마취제, 항생제, 진통제, 기타)
- 제형별(스프레이, 점비약, 분말, 젤·연고)
- 치료 용도별(천식, 만성폐쇄성폐질환(COPD), 비염, 낭포성섬유증, 비폐)
- 최종사용자별(재택의료 환경, 병원, 진료소)
- 지역별
- 기업별(2024)
시장 맵

제6장 북미의 경비 약물전달 시장 전망

시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
- 미국
- 캐나다
- 멕시코

제7장 유럽의 경비 약물전달 시장 전망

시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인

제8장 아시아태평양의 경비 약물전달 시장 전망

시장 규모 및 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
- 중국
- 인도
- 일본
- 한국
- 호주

제9장 중동 및 아프리카의 경비 약물전달 시장 전망

시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
- 사우디아라비아
- 아랍에미리트
- 남아프리카공화국

제10장 남미의 경비 약물전달 시장 전망

시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
- 브라질
- 콜롬비아
- 아르헨티나

제11장 시장 역학

성장 촉진요인
과제

제12장 시장 동향과 발전

인수합병
제품 출시
최근 동향

제13장 세계의 경비 약물전달 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

업계내 경쟁
신규 참여의 가능성
공급업체의 능력
고객의 능력
대체품의 위협

제15장 경쟁 구도

GlaxoSmithKline Plc
Pfizer, Inc.
AstraZeneca PLC
Novartis AG
Becton Dickson & Company
Cadila Pharmaceuticals Ltd.
3M Company
Johnson & Johnson
Sanofi S.A.
Merck & Co., Inc.

제16장 전략적 제안

제17장 조사 회사 소개 및 면책사항

KSM

영문 목차

영문목차

The Global Nasal Drug Delivery Market, valued at USD 59.67 Billion in 2024, is projected to experience a CAGR of 7.66% to reach USD 92.91 Billion by 2030. Nasal drug delivery involves administering therapeutic agents directly to the nasal cavity for local or systemic absorption, utilizing its rich vascularization and the potential for direct brain access. Main drivers supporting this market's growth include increasing patient preference for non-invasive drug administration, the rapid onset of action, and the avoidance of hepatic first-pass metabolism, which collectively enhance drug bioavailability and therapeutic efficacy. The rising prevalence of chronic respiratory conditions and the demand for convenient self-administration methods also notably contribute to market expansion.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 59.67 Billion
Market Size 2030	USD 92.91 Billion
CAGR 2025-2030	7.66%
Fastest Growing Segment	Corticosteroids
Largest Market	North America

Key Market Drivers

The increasing patient preference for non-invasive drug administration significantly influences the growth trajectory of the global nasal drug delivery market. Patients often favor routes that minimize discomfort and inconvenience, promoting better adherence to treatment regimens, particularly for long-term therapies or conditions requiring frequent dosing. This preference is evident in a broad range of therapeutic areas, driving pharmaceutical companies to develop and optimize nasal formulations for conditions traditionally managed by injectables.

Key Market Challenges

The inherent limitation of drug permeability across the nasal mucosal barrier presents a significant constraint on the growth of the Global Nasal Drug Delivery Market. This physiological hurdle complicates the formulation and effective systemic or even local delivery of large molecule pharmaceuticals, such as peptides, proteins, and antibodies. These larger therapeutic agents often struggle to traverse the tightly regulated nasal lining, hindering their optimal absorption into the bloodstream or direct access to the brain.

Key Market Trends

Nose-to-brain delivery for central nervous system (CNS) therapeutics represents an emerging and highly promising approach that exploits the unique anatomical pathways of the nasal cavity to bypass the blood-brain barrier and deliver drugs directly to the brain. This targeted route enables higher therapeutic concentrations in the CNS while reducing systemic exposure and minimizing associated side effects. As a result, it offers significant potential for the treatment of complex neurological and psychiatric disorders, including Alzheimer's and Parkinson's diseases, where conventional delivery methods often face limited efficacy.

Key Market Players

GlaxoSmithKline Plc
Pfizer, Inc.
AstraZeneca PLC
Novartis AG
Becton Dickson & Company
Cadila Pharmaceuticals Ltd.
3M Company
Johnson & Johnson
Sanofi S.A.
Merck & Co., Inc.

Report Scope:

In this report, the Global Nasal Drug Delivery Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Nasal Drug Delivery Market, By Drug Type:

Antihistamines
Corticosteroids
Anesthetics
Antibiotics
Pain Relief Drugs
Others

Nasal Drug Delivery Market, By Dosage Form:

Sprays
Drops
Powder
Gels & Ointments

Nasal Drug Delivery Market, By Therapeutic Application:

Asthma
Chronic Obstructive Pulmonary Disease (COPD)
Rhinitis
Cystic Fibrosis
Nasal Congestion

Nasal Drug Delivery Market, By End User:

Home Care Settings
Hospitals
Clinics

Nasal Drug Delivery Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Nasal Drug Delivery Market.

Available Customizations:

Global Nasal Drug Delivery Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Nasal Drug Delivery Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Drug Type (Antihistamines, Corticosteroids, Anesthetics, Antibiotics, Pain Relief Drugs, Others)
- 5.2.2. By Dosage Form (Sprays, Drops, Powder, Gels & Ointments)
- 5.2.3. By Therapeutic Application (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Rhinitis, Cystic Fibrosis, Nasal Congestion)
- 5.2.4. By End User (Home Care Settings, Hospitals, Clinics)
- 5.2.5. By Region
- 5.2.6. By Company (2024)
5.3. Market Map

6. North America Nasal Drug Delivery Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Drug Type
- 6.2.2. By Dosage Form
- 6.2.3. By Therapeutic Application
- 6.2.4. By End User
- 6.2.5. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Nasal Drug Delivery Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Drug Type
    - 6.3.1.2.2. By Dosage Form
    - 6.3.1.2.3. By Therapeutic Application
    - 6.3.1.2.4. By End User
- 6.3.2. Canada Nasal Drug Delivery Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Drug Type
    - 6.3.2.2.2. By Dosage Form
    - 6.3.2.2.3. By Therapeutic Application
    - 6.3.2.2.4. By End User
- 6.3.3. Mexico Nasal Drug Delivery Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Drug Type
    - 6.3.3.2.2. By Dosage Form
    - 6.3.3.2.3. By Therapeutic Application
    - 6.3.3.2.4. By End User

7. Europe Nasal Drug Delivery Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Drug Type
- 7.2.2. By Dosage Form
- 7.2.3. By Therapeutic Application
- 7.2.4. By End User
- 7.2.5. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Nasal Drug Delivery Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Drug Type
    - 7.3.1.2.2. By Dosage Form
    - 7.3.1.2.3. By Therapeutic Application
    - 7.3.1.2.4. By End User
- 7.3.2. France Nasal Drug Delivery Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Drug Type
    - 7.3.2.2.2. By Dosage Form
    - 7.3.2.2.3. By Therapeutic Application
    - 7.3.2.2.4. By End User
- 7.3.3. United Kingdom Nasal Drug Delivery Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Drug Type
    - 7.3.3.2.2. By Dosage Form
    - 7.3.3.2.3. By Therapeutic Application
    - 7.3.3.2.4. By End User
- 7.3.4. Italy Nasal Drug Delivery Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Drug Type
    - 7.3.4.2.2. By Dosage Form
    - 7.3.4.2.3. By Therapeutic Application
    - 7.3.4.2.4. By End User
- 7.3.5. Spain Nasal Drug Delivery Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Drug Type
    - 7.3.5.2.2. By Dosage Form
    - 7.3.5.2.3. By Therapeutic Application
    - 7.3.5.2.4. By End User

8. Asia Pacific Nasal Drug Delivery Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Drug Type
- 8.2.2. By Dosage Form
- 8.2.3. By Therapeutic Application
- 8.2.4. By End User
- 8.2.5. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Nasal Drug Delivery Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Drug Type
    - 8.3.1.2.2. By Dosage Form
    - 8.3.1.2.3. By Therapeutic Application
    - 8.3.1.2.4. By End User
- 8.3.2. India Nasal Drug Delivery Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Drug Type
    - 8.3.2.2.2. By Dosage Form
    - 8.3.2.2.3. By Therapeutic Application
    - 8.3.2.2.4. By End User
- 8.3.3. Japan Nasal Drug Delivery Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Drug Type
    - 8.3.3.2.2. By Dosage Form
    - 8.3.3.2.3. By Therapeutic Application
    - 8.3.3.2.4. By End User
- 8.3.4. South Korea Nasal Drug Delivery Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Drug Type
    - 8.3.4.2.2. By Dosage Form
    - 8.3.4.2.3. By Therapeutic Application
    - 8.3.4.2.4. By End User
- 8.3.5. Australia Nasal Drug Delivery Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Drug Type
    - 8.3.5.2.2. By Dosage Form
    - 8.3.5.2.3. By Therapeutic Application
    - 8.3.5.2.4. By End User

9. Middle East & Africa Nasal Drug Delivery Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Drug Type
- 9.2.2. By Dosage Form
- 9.2.3. By Therapeutic Application
- 9.2.4. By End User
- 9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Nasal Drug Delivery Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Drug Type
    - 9.3.1.2.2. By Dosage Form
    - 9.3.1.2.3. By Therapeutic Application
    - 9.3.1.2.4. By End User
- 9.3.2. UAE Nasal Drug Delivery Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Drug Type
    - 9.3.2.2.2. By Dosage Form
    - 9.3.2.2.3. By Therapeutic Application
    - 9.3.2.2.4. By End User
- 9.3.3. South Africa Nasal Drug Delivery Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Drug Type
    - 9.3.3.2.2. By Dosage Form
    - 9.3.3.2.3. By Therapeutic Application
    - 9.3.3.2.4. By End User

10. South America Nasal Drug Delivery Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Drug Type
- 10.2.2. By Dosage Form
- 10.2.3. By Therapeutic Application
- 10.2.4. By End User
- 10.2.5. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Nasal Drug Delivery Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Drug Type
    - 10.3.1.2.2. By Dosage Form
    - 10.3.1.2.3. By Therapeutic Application
    - 10.3.1.2.4. By End User
- 10.3.2. Colombia Nasal Drug Delivery Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Drug Type
    - 10.3.2.2.2. By Dosage Form
    - 10.3.2.2.3. By Therapeutic Application
    - 10.3.2.2.4. By End User
- 10.3.3. Argentina Nasal Drug Delivery Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Drug Type
    - 10.3.3.2.2. By Dosage Form
    - 10.3.3.2.3. By Therapeutic Application
    - 10.3.3.2.4. By End User

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Nasal Drug Delivery Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. GlaxoSmithKline Plc
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. Pfizer, Inc.
15.3. AstraZeneca PLC
15.4. Novartis AG
15.5. Becton Dickson & Company
15.6. Cadila Pharmaceuticals Ltd.
15.7. 3M Company
15.8. Johnson & Johnson
15.9. Sanofi S.A.
15.10. Merck & Co., Inc.